October 3, 2011
Taiho Pharmaceutical has launched the antitumor agent Zolinza Capsules 100 mg (vorinostat) for the treatment of cutaneous T-cell lymphoma (CTCL). The NHI price is ¥5,462.80 per 100 mg capsule. The data released by Chuikyo forecasts peak sales of ¥1.6 billion...read more